Stephens & Co. Reiterates Overweight on Itron, Maintains $130 Price Target
Benzinga Newsdesk 5 months ago
NewsPrice TargetReiterationAnalyst Ratings
Stephens & Co. analyst Tommy Moll reiterates Itron (NASDAQ:ITRI) with a Overweight and maintains $130 price target.
Stephens & Co. analyst Tommy Moll reiterates Itron (NASDAQ:ITRI) with a Overweight and maintains $130 price target.